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The production of human pluripotent stem cell derived cardiomyocytes (hPSC-CMs) holds great promise for 
cardiotoxicity drug testing, disease modeling and cardiac regeneration. However, the complex nets of signaling 
pathways involved in cardiomyogenesis compromises the effectiveness of the existing differentiation protocols 
to reproducibly produce high-quality hPSC-CMs. Produced hPSC-CMs are immature compared with adult CMs, 
express typical fetal cardiac genes, use glucose as major energy source and have immature structural and 
electrophysiological properties. In this study we aim to overcome these hurdles by devising an integrated 
strategy for production and maturation of functional hPSC-CMs. hPSC (hiPSC and hESC lines) were 
differentiated into CMs, using a novel directed differentiation protocol. CM differentiation was monitored by flow 
cytometry, qRT-PCR and proteomic analyses. Different medium compositions were tested aiming to improve 
hPSC-CM maturation after differentiation. Metabolome, fluxome and transcriptome analyses as well as 
structural, ultrastructural and functionality analyses were used to evaluate the impact of feeding strategies on 
hiPSC-CM maturation.  
 
We showed that our differentiation protocol originates pure 2D monolayers and 3D aggregates of hiPSC-CMs 
that present typical CM transcriptome and proteome profiles.  
 
Combining a set of “-omics” tools (metabolomics, fluxomics and transcriptomics) with structural and 
morphological analyses we demonstrated that hiPSC-CM cultured in glucose depleted medium supplemented 
with fatty acids display features that resemble more mature CMs, than hiPSC-CMs cultured in standard glucose 
rich medium, namely: energetically efficient oxidative metabolism, transcriptional signatures closer to ventricular 
CM; more elongated morphologies; organized sarcomeric structures and higher myofibril density and alignment. 
Comprehensive physiological characterization further demonstrated improved calcium handling, enhanced 
contractility, and more physiological action potential kinetics within 10 days in fatty acid-containing media. 
This work describes significant advances towards production of mature functional hPSC-CMs, meeting some of 
the needs of the cardiac regenerative medicine market and industrial field. 
 
